SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

SVB Leerink Initiates Coverage On Recursion Pharmaceuticals with Outperform Rating, Announces Price Target of $33

SVB Leerink analyst Mani Foroohar initiates coverage on Recursion Pharmaceuticals (NASDAQ:RXRX) with a Outperform rating and announces Price Target of $33.

05/11/2021 08:45
SVB Leerink analyst Mani Foroohar initiates coverage on Recursion Pharmaceuticals (NASDAQ:RXRX) with a Outperform rating and announces Price Target of $33.